The aim of this study is to demonstrate the beneficial effects on gut microbiota composition and activity of the diary intake of insoluble fiber (extract from Aspergillus Niger) for three weeks. The first studies about the fiber have shown a favorable gut microbiota modulation and an improvement of metabolic parameters like LDL cholesterol. In addition to fecal measurements, several biomarkers of colic fermentation will be assessed: expired gases, PolyUnsaturated Fatty Acid, Short Chain Fatty Acid (SCFA) after a rich-fiber breakfast (= 15 grams) and a nutritional challenge test at lunch. The gastrointestinal tolerance of fiber intake and the intestinal transit modification will be also followed during all the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
19
The volunteers will take three times a day one bag of powder containing 1.5g of chitin-glucan fiber during three weeks. The powder will be diluted in water.
The volunteers will take three times a day one bag of powder containing placebo during three weeks. The powder will be diluted in water.
Centre de Recherche en Nutrition Humaine Rhône-Alpes - Centre hospitalier Lyon Sud
Pierre-Bénite, France
Fecal SCFA
Change from baseline fecal SCFA at three weeks by Gas chromatography-Flame Ionization Detector
Time frame: baseline and three weeks
gut microbiota composition
Change from baseline gut microbiota composition by 16SrDNA Illimina Sequencing
Time frame: baseline and three weeks
fecal biliary acids
Change from baseline fecal biliary acids by FAME quantification (gas-liquid chromatography)
Time frame: baseline and three weeks
fecal PolyUnsaturated Fatty Acids (PUFA)
Change from baseline fecal PolyUnsaturted Fatty Acids (PUFA) by FAME quantification (gas-liquid chromatography)
Time frame: baseline and three weeks
fecal albumin
Change from baseline fecal albumin by immunoenzymatic technique (ELISA)
Time frame: baseline and three weeks
fecal zonulin
Change from baseline fecal zonulin by immunoenzymatic technique (IDK Zonulin ELISA)
Time frame: baseline and three weeks
fecal calprotectin
Change from baseline fecal calprotectin by Phadia 100 system
Time frame: baseline and three weeks
TLR-agonist in stool
Change from baseline TRL-agonist in stool using the HEK-Blue™ TLR cellules
Time frame: baseline and three weeks
Change from baseline CO2, CH4 and H2 kinetics in exhaled gases
by gas chromatography, during ten hours after rich-fiber breakfast and nutritional challenge test at lunch
Time frame: baseline and three weeks
body composition
Change from baseline bodycompositio by bioimpedancemetry
Time frame: baseline and three weeks
Change from plasma glucose kinetics
by spectrophotometry method , during seven hours after rich-fiber breakfast and nutritional challenge test at lunch
Time frame: baseline and three weeks
Change from plasma insulin kinetics
by radio-immuno analysis , during seven hours after rich-fiber breakfast and nutritional challenge test at lunch
Time frame: baseline and three weeks
Change from plasma Non-Esterifies Fatty-Acid (NEFA) kinetics
by spectrophotometry method , during seven hours after rich-fiber breakfast and nutritional challenge test at lunch
Time frame: baseline and three weeks
plasma TriacylGlycerol (TG) kinetics
Change from plasma TriacylGlycerol (TG) kinetics by spectrophotometry method , during seven hours after rich-fiber breakfast and nutritional challenge test at lunch
Time frame: baseline and three weeks
Cholesterol Total, Cholesterol LDL
Change from baseline cholesterol Total, Cholesterol LDL by spectrophotometry method
Time frame: baseline and three weeks
resting energy expenditure
Change from baseline resting energy expenditure by indirect calorimetry
Time frame: baseline and three weeks
stool consistency
by Bristol Stool Chart (type1-7)
Time frame: every week, up to three weeks
stool frequency
by questionnaire
Time frame: every week, up to three weeks
gastro-intestinal symptoms
by questionnaires and visual analogue scale (VAS) score (on a 90mm horizontal line; from no symptom (minimal) to serious symptom (maximum))
Time frame: every week, up to three weeks
quality of life during the study
change from baseline quality of life during the study by SF 36 questionnaire
Time frame: baseline and three weeks
change from baseline dietary intake of fibre
by three day food record
Time frame: baseline and three weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.